Statins linked to reduced liver cancer risk in major cohort study
Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...
MedPage Today on MSN4d
Statin Use Linked With Reduced Risks in Chronic Liver Disease
Statin use in patients with chronic liver disease was associated with a reduced risk of hepatocellular carcinoma (HCC) and ...
Oncology Nurse Advisor17h
Allo-HSCT After CAR-T Offers Meaningful Benefits for Patients With R/R B-ALL
Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival.
HealthDay on MSN1d
Statins May Reduce Risk for Hepatocellular Carcinoma in Chronic Liver Disease
For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and ...
HealthDay on MSN16d
One-Hour Glucose on OGTT at Three Months Postpartum Predicts Dysglycemia
Higher one-hour blood glucose on an oral glucose tolerance test (OGTT) at three months postpartum can predict the risk for dysglycemia at five years, according to a study published online March 3 in ...
MPR1d
GLP-1 RA Use Tied to Better Kidney Transplant Outcomes in Patients With Diabetes
HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with better graft and patient survival among kidney transplant recipients with diabetes, according to a study ...
CURE2d
Orca-T Doubles Graft-Versus-Host Disease-Free Survival in Leukemia
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...